Mechanisms of Gastrointestinal Growth and Transformation

胃肠道生长和转化的机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): The intestinal enterochromaffin cell (EC) compartment expands in response to acute injury, microbial infection and colitis to produce serotonin (5-hydroxytryptamine, 5HT). Elevated levels of plasma serotonin stimulate fluid secretion and gut motility to expel the infectious or toxic irritants. Although an essential component of the innate immune response, these gut functions contribute to patient discomfort and if sustained become a source of significant morbidity and possible mortality. Despite its central role, it is not understood what regulates EC cell function. During the prior funding cycle, we found that the zinc finger transcription factor ZBP-89 interacts directly with the tumor suppressor protein ataxia telangiectasia mutated (ATM) in response to histone deacetylase inhibition (HDACi), e.g., butyrate or trichostatin A (TSA). Butyrate induces ZBP-89 expression and binding to GC-rich DNA elements in several promoters including the cyclin-dependent kinase inhibitor (CDKI) p21. Butyrate also triggers auto-phosphorylation of ATM at serine 1981 (pATMS1981) that subsequently complexes with ZBP-89 to activate p21. In the current proposal, pATMS1981 positive expression in the gut was found to occur exclusively in the cytoplasm of intestinal EC cells suggesting that pATMS1981 participates in an essential function of these cells. Mice conditionally null for ZBP-89 in the colon exhibited reduced numbers of EC cells and reduced tryptophan hydroxylase 1 gene (TPH1) transcripts on a microarray. Indeed, we found GC-rich DNA elements in the proximal promoter of the TPH1 gene, the rate-limiting synthetic enzyme for 5HT biosynthesis. In addition, pATMS1981-expressing cells in APCmin polyps were absent suggesting that excess Wnt signaling prevents EC cell differentiation. In the current application, three aims are proposed to test the overarching hypothesis that ZBP-89 stimulates serotonin production in gut EC cells by regulating TPH1 gene expression while pATM in the cytoplasm regulates 5HT release. Moreover, we hypothesize that inflammation perturbs their function setting the stage for neoplastic transformation. In Aim 1, we will determine how ZBP-89- regulates TPH1 gene expression. In Aim 2, we will dissect the role of pATMS1981 in butyrate-mediated secretion of 5HT. In Aim 3, we will study the role of these two proteins in 5HT biosynthesis during chronic inflammation and colonic transformation. Collectively, these studies will establish a link between ZBP-89 and pATMS1981, in the biosynthesis and function of 5HT in response to luminal butyrate.
描述(由申请人提供):肠肠嗜铬细胞(EC)室在急性损伤、微生物感染和结肠炎时扩张,产生5-羟色胺(5-羟色胺,5HT)。血浆血清素水平升高会刺激体液分泌和肠道运动以排出感染性或毒性刺激物。虽然是先天免疫反应的重要组成部分,但这些肠道功能会导致患者不适,如果持续下去,就会成为显著发病率和可能死亡率的来源。尽管它具有中心作用,但调控EC细胞功能的机制尚不清楚。在之前的资助周期中,我们发现锌指转录因子ZBP-89与肿瘤抑制蛋白ataxia毛细血管扩张突变(ATM)直接相互作用,以响应组蛋白去乙酰化酶抑制(HDACi),例如丁酸盐或trichostatin A (TSA)。丁酸盐诱导ZBP-89在包括细胞周期蛋白依赖性激酶抑制剂(CDKI) p21在内的多种启动子中表达并与富含gc的DNA元件结合。丁酸盐还能触发ATM丝氨酸1981 (pATMS1981)的自磷酸化,随后与ZBP-89复合物激活p21。在目前的研究中,发现肠道中pATMS1981的阳性表达仅发生在肠EC细胞的细胞质中,这表明pATMS1981参与了这些细胞的基本功能。在微阵列上显示,结肠条件阴性ZBP-89的小鼠EC细胞数量减少,色氨酸羟化酶1基因(TPH1)转录物减少。事实上,我们在TPH1基因的近端启动子中发现了富含gc的DNA元素,TPH1基因是5HT生物合成的限速合成酶。此外,在APCmin息肉中没有表达patms1981的细胞,这表明过量的Wnt信号传导阻止了EC细胞的分化。在目前的应用中,提出了三个目的来验证ZBP-89通过调节TPH1基因表达刺激肠EC细胞血清素产生,而细胞质中的pATM调节5HT释放的总体假设。此外,我们假设炎症干扰了它们的功能,为肿瘤转化奠定了基础。在Aim 1中,我们将确定ZBP-89-如何调节TPH1基因表达。在Aim 2中,我们将剖析pATMS1981在丁酸盐介导的5HT分泌中的作用。在Aim 3中,我们将研究这两种蛋白在慢性炎症和结肠转化过程中5HT生物合成中的作用。总的来说,这些研究将建立ZBP-89和pATMS1981之间的联系,在5HT的生物合成和功能响应于luminal butyrate。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JUANITA L. MERCHANT其他文献

JUANITA L. MERCHANT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JUANITA L. MERCHANT', 18)}}的其他基金

MDSC Polarization and Helicobacter-Induced Gastric Metaplasia
MDSC 极化和螺杆菌诱导的胃化生
  • 批准号:
    10164764
  • 财政年份:
    2018
  • 资助金额:
    $ 32.53万
  • 项目类别:
MDSC Polarization and Helicobacter-induced Gastric Metaplasia
MDSC 极化和螺杆菌诱导的胃化生
  • 批准号:
    10687293
  • 财政年份:
    2018
  • 资助金额:
    $ 32.53万
  • 项目类别:
Mechanisms of Gastrointestinal Growth and Transformation
胃肠道生长和转化的机制
  • 批准号:
    8088362
  • 财政年份:
    2010
  • 资助金额:
    $ 32.53万
  • 项目类别:
Mechanisms of Gastrointestional Growth & Transformation
胃肠生长机制
  • 批准号:
    7895949
  • 财政年份:
    2009
  • 资助金额:
    $ 32.53万
  • 项目类别:
Cellular Decisions of Differentiation in the GI Tract
胃肠道分化的细胞决定
  • 批准号:
    7898168
  • 财政年份:
    2009
  • 资助金额:
    $ 32.53万
  • 项目类别:
MOLECULAR BIOLOGY CORE
分子生物学核心
  • 批准号:
    7002129
  • 财政年份:
    2005
  • 资助金额:
    $ 32.53万
  • 项目类别:
Altering Gastric Epithelial Cell Differentiation
改变胃上皮细胞分化
  • 批准号:
    6698037
  • 财政年份:
    2003
  • 资助金额:
    $ 32.53万
  • 项目类别:
Altering Gastric Epithelial Cell Differentiation
改变胃上皮细胞分化
  • 批准号:
    7174208
  • 财政年份:
    2003
  • 资助金额:
    $ 32.53万
  • 项目类别:
Altering Gastric Epithelial Cell Differentiation
改变胃上皮细胞分化
  • 批准号:
    6858685
  • 财政年份:
    2003
  • 资助金额:
    $ 32.53万
  • 项目类别:
Altering Gastric Epithelial Cell Differentiation
改变胃上皮细胞分化
  • 批准号:
    6577518
  • 财政年份:
    2003
  • 资助金额:
    $ 32.53万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了